Sogol Mostoufi-Moab, MD, MSCE

Sogol Mostoufi-Moab, MD, MSCE

Sogol Mostoufi-Moab, MD, MSCE, is a dual-certified pediatric oncologist and endocrinologist with clinical expertise in endocrine late effects after childhood cancer therapy.

Areas of Expertise: Endocrine late effects in survivors of childhood cancer, Thyroid cancer
Locations: Main Campus
Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467)

Background

I am a dual-certified pediatric oncologist and endocrinologist with clinical expertise in endocrine late effects after childhood cancer therapy.

The development of intensified oncology treatment regimens has greatly improved the survival of children with cancer. Currently, more than 80 percent of children with acute lymphoblastic leukemia (ALL) and upwards of 50 percent of pediatric patients treated for solid tumors will survive into adulthood. Similarly, five-year cure rates for childhood Bone Marrow Transplantation (BMT) exceed 60 percent. It is estimated that by 2014, 1 in every 250 adults will be a survivor of childhood cancer.

However, treatment-related disorders of endocrine systems are common in this growing population of cancer survivors. As the endocrinologist for the Cancer Survivorship Program, I treat childhood cancer survivors with endocrine abnormalities such as abnormal growth, thyroid disorders, pubertal disorders, and thyroid malignancy.

Over the course of my unique dual training, I developed an interest in understanding childhood bone health and cancer treatment-related threats to childhood skeletal development. Cancer survivors are at risk for poor bone health, given their numerous endocrine morbidities. Skeletal development during childhood is characterized by specific changes in bone dimensions with coordinated actions of growth hormone and sex steroids in the setting of adequate biomechanical loading and nutrition.

Chemotherapy, irradiation, steroid exposure, poor muscle strength, vitamin D deficiency and poor nutrition all negatively impact the growing, vulnerable skeleton in this at-risk patient population. Understandably, a multidisciplinary team care approach is necessary to provide comprehensive care for this growing patient population with various treatment-related morbidities. I have been lucky to be part of the wonderful Cancer Survivorship team at Children's Hospital, providing necessary care to these patients.

Children's Hospital houses one of the premier childhood cancer programs for research, training and comprehensive care in the world. The division of oncology treats many newly diagnosed patients from different regions each year, and also has a national referral base for complex cases. We have successfully integrated a state-of-the-art basic, translational and clinical research environment dedicated to eradicating the pain and suffering caused by cancer in children.

My research program focuses on bone health and body composition abnormalities in childhood cancer survivors. My dual training experience provides me with unique expertise for treatment of multiple, complex endocrine abnormalities after various childhood cancer regimens such as high risk neuroblastoma treatment.

As a pediatric oncologist and endocrinologist at Children's Hospital, I have been blessed with outstanding individualized mentorship and role models in providing the best care for children with cancer. Treating children with cancer is my passion and addressing life-long treatment-related challenges in survivors of childhood cancer my ultimate goal. I am proud to be at Children's Hospital and part of the team.

Education and Training

Medical School

MD - The Pennsylvania State University-Hershey Medical Center, Hershey, PA

Internship

Pediatrics - The Children's Hospital of Philadelphia, Philadelphia, PA

Residency

Pediatrics - The Children's Hospital of Philadelphia, Philadelphia, PA

Fellowship

Pediatric Endocrinology - The Children's Hospital of Philadelphia, Philadelphia, PA
Pediatric Hematology & Oncology - The Children's Hospital of Philadelphia, Philadelphia, PA

Board Certification

Pediatric Endocrinology
Pediatric Hematology-Oncology
Pediatrics

Graduate Degree

Master of Science in Clinical Epidemiology (MSCE) - University of Pennsylvania, Philadelphia, PA

Titles and Academic Titles

Attending Physician

Assistant Professor, Perelman School of Medicine at the University of Pennsylvania

Conditions Treated

Departments and Services

Research Interests

Bone health in survivors of bone marrow transplantation
Endocrine Late Effects after Childhood Cancer Therapy

Publications

Papers

2016

Mostoufi-Moab S, Seidel K, Leisenring WM, Armstrong GT, Oeffinger KC, Stovall M, Meacham LR, Green DM, Weathers R, Ginsberg JP, Robison LL, Sklar CA. Endocrine abnormalities in aging survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2016;34(27): 3240-3247.

2015

Noyes JJ, Levine MA, Mostoufi-Moab S.  Premature Epiphyseal Closure of the Lower Extremities Contributing to Short Stature after Cis-Retinoic Acid Therapy in Medulloblastoma:  A Case Report.  Hormone Res Paediatr, October 13, 2015.  PMID:26457578

Baker JF, Von Feldt JM, Mostoufi-Moab S, Kim W, Taratuta E, Leonard MB.  Insulin-Like Growth Factor-1 and Adiponectin and Associations with Muscle Deficits, Disease Characteristics, and Treatments in Rheumatoid Arthritis.  The Journal of Rheumatology 24(11):  2038-45, 2015.  PMID:26329340.

Kovatch KJ, Bauer AJ, Isaacoff EJ, Prickett KK, Adzick NS, Kazahaya K, Sullivan LM, Mostoufi-Moab S. Pediatric Thyroid Carcinoma in Patients with Graves’ Disease: The Role of Ultrasound in Selecting Patients for Definitive Therapy. Horm Res Paediatr. 2015 Apr 15. [Epub ahead of print]

Mostoufi-Moab S, Magland J, Isaacoff EJ, Sun W, Rajapakse CS, Zemel B, Wehrli F, Shakdar K, Baker J, Long J, Leonard MB. Adverse Fat Depots and Marrow Adiposity Are Associated with Skeletal Deficits and Insulin Resistance in Long-Term Survivors of Pediatric Hematopoietic Stem Cell Transplantation. J Bone Miner Res. 2015 Sep;30(9):1657-66. doi: 10.1002/jbmr.2512. Epub 2015 May 10.

2014

Baker JF, Von Feldt J, Mostoufi-Moab S, Nosieh G, Taratuta E, Kim W, Leonard MB. Deficits in muscle mass, muscle density, and modified associations with fat in rheumatoid arthritis. Arthritis Care Res. 2014 Nov;66(11):1612-8. PMID:24664868

Mostoufi-Moab S, Leonard MB. Re: Slipped capital femoral epiphysis after total body irradiation. Pediatr Blood Cancer. 2014 Jun;61(6):1141. PMID:24375952

Books

Chapters

2014

Mostoufi-Moab S, Halton J.  Bone morbidity in childhood leukemia: Epidemiology, mechanisms, diagnosis and treatment.  Curr Osteoporos Rep 12(3): 300-12, 2014. PMID:24986711

2012

Mostoufi-Moab S, Bauer AJ.  Differentiated Thyroid Cancer in Children and Adolescents. In:  Wartofsky L (eds.), Thyroid Cancer: A Clinical Guide. 3rd Edition. Humana Press, 2012.

Mostoufi-Moab S, Magge S.  Diabetes Insipidus.  In: Schwartz WM, Bell LM, Bingham PM, Chung EK, Friedman DF, Loomes KM, Mamula P, Mascarenhas MR, Tanel RE (eds.), The 5-Minute Pediatric Consult. 6th Edition.  Philadelphia: Lippincott Williams & Wilkins, 2012.

2009

Moshang T, Mostoufi-Moab S.  Endocrine Problems in Pediatric Cancer Survivors.  In:  Sarafoglou K.  Pediatric Endocrinology and Inborn Errors of Metabolism.  New York: McGraw Hill Companies, 2009.

20

Mostoufi-Moab S, Yan A. Dermatology.  In: Frank G, Shah SS, Catallozzi MC, Zaoutis LB (eds.), Philadelphia Guide to Inpatient Pediatrics. 3rd Edition.  Molden, MA:  Blackwell Publishing, 2005.

Posters and Presentations

2015

Barakat LP, Mostoufi-Moab S, Pierce L, Linton K, Bauer AJ. Health-related quality of life among adolescents and young adults with differentiated thyroid carcinoma: Family risk and posttraumatic stress and growth. 2015 AAP National Conference and Exhibition Washington DC October 2015 (Poster presentation)

Mostoufi-Moab S, Seidel K, Leisenring WM, Armstrong GT, Oeffinger KC, Green DM, Stovall M, Meacham LR, Ginsberg J, Robinson LL, Sklar CA. Endocrine disorders in adult survivors of childhood cancer: A report from the childhood cancer survivor study (CCSS). 14th International Conference on Long-Term Complications of Treatment of Children and Adolescents for Cancer Arlington, VA June 2015 (Oral platform presentation)

Mostoufi-Moab S, Magland J, Isaacoff E, Sun W, Rajapakse CS, Zemel B, Wehrli F, Shekdar K, Baker J, Long J, Leonard MB. Adverse fat depots, marrow adiposity, and skeletal deficits in long-term survivors of pediatric hematopoietic stem cell transplantation. 2015 ASCO Annual Meeting Chicago, IL May 2015 (Poster presentation)

2014

Mostoufi-Moab S, Sun W, Maglan J, Isaacoff E, Ginsberg JP, Wherli F, Leonard MB.  Increased vertebral marrow adiposity in long-term survivors of pediatric allogeneic hematopoietic stem cell transplant is associated with deficits in trabecular microarchitecture.  Endocrine Society Chicago, IL June 2014 (Oral platform presentation)

Invited Lectures

2014

Impact of Childhood Cancer Therapy on Pediatric Bone Accrual, MSKCC Pediatric Oncology Grand Rounds, New York, NY, November 2014.

Childhood Cancer Therapy Impact on Bone Accrual:  A Survivorship Perspective, Emory Pediatric Oncology Grand Rounds, Atlanta, Georgia, September 2014.

Endocrine Late Effects in Survivors of High Risk Neuroblastoma, Neuroblastoma Parent Conference, Chicago, IL, July 2014.

Skeletal Deficits and Enhanced Adiposity in Survivors of Childhood Hematopoietic Stem Cell Transplantation, Endocrine Society Fat & Bone Symposium, Chicago, IL, June 2014.

American Austrian Foundation, Pediatric Endocrine Course, Salzburg, Austria, May 2014.

Bone Metabolism and Impact of Childhood Cancer Therapy on Bone Accrual, ASPHO Bone in Pediatric Cancer Symposium, Chicago, IL, May 2014.

Awards and Honors

2011, Pediatric Blood and Marrow Transplant Consortium Travel Grant Recipient

2007, Genentech Clinical Fellows Travel Grant Recipient

2004, William Pottash Fellow Teacher of the Year Award

2003, The Children’s Hospital of Philadelphia Physician Partnering Award

2000, Janet M. Glasgow Memorial Award

2000, Department of Pediatrics Award for Outstanding Achievement

2000, The Endocrine Society Medical Student Outstanding Achievement

2000, Medical Student Research Symposium Award

1998, Alpha Omega Alpha

1996 - 1999, Hammond Jr. Memorial Scholarship Award for Academic Achievement

1996, McGraw Hill Award for Academic Achievement 1996

1991 - 1995, University of Missouri full tuition merit scholarship

1995, University of Missouri Outstanding Biological Student Award

1995, Phi Beta Kappa

1994, Mortar Board

1993, Golden Key National Honor Society Outstanding Junior Award

1992, Wurdack Agriculture Scholarship for Academic Achievement

1992, Phi Eta Sigma

Editorial and Academic Positions

Editorial Positions

Manuscript Reviewer

2013-present, Journal of Clinical Oncology

2012-present, Journal of Bone Mineral Research

2011-present, Pediatric Blood and Cancer

2010-present, Journal of Clinical Endocrine & Metabolism

Academic and Institutional Committees

2014 - present, Children’s Oncology Group Survivorship and Outcomes Steering Committee

2013 - present, Childhood Cancer Survivor Study, Chronic Disease Working Group

Leadership and Memberships

Memberships in Professional Organizations

2013 - present, Children’s Oncology Group

2012-present, American Society of Clinical Oncology

2012-present, American Thyroid Association

2010-present, American Society of Pediatric Hematology & Oncology

2006-present, Endocrine Society